DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,865 | -21.7% | 24,092 | -1.7% | 0.00% | – |
| Q2 2023 | $275,799 | +123.7% | 24,500 | +128.9% | 0.00% | – |
| Q1 2023 | $123,310 | +2.1% | 10,704 | +2.7% | 0.00% | – |
| Q4 2022 | $120,791 | -9.2% | 10,422 | 0.0% | 0.00% | – |
| Q3 2022 | $133,000 | +51.1% | 10,422 | -18.3% | 0.00% | – |
| Q2 2022 | $88,000 | +14.3% | 12,757 | +59.9% | 0.00% | – |
| Q1 2022 | $77,000 | -18.9% | 7,978 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | -26.4% | 7,978 | 0.0% | 0.00% | – |
| Q3 2021 | $129,000 | +81.7% | 7,978 | +134.6% | 0.00% | – |
| Q2 2021 | $71,000 | +163.0% | 3,401 | +98.2% | 0.00% | – |
| Q1 2021 | $27,000 | -12.9% | 1,716 | +16.2% | 0.00% | – |
| Q4 2020 | $31,000 | +210.0% | 1,477 | +198.4% | 0.00% | – |
| Q3 2020 | $10,000 | – | 495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |